Back to Search
Start Over
The 11th Asia-Pacific League of Associations for Rheumatology Congress (APLAR 2004): JCR Sponsored Symposium “Efficacy and Safety of TNF-alpha Blockers in Rheumatoid Arthritis” September 12 (Sunday), 2004, 14:00-15:30, Jeju, Korea 1. Efficacy and safety of infliximab in the treatment of Japanese rheumatoid arthritis patients 2. Expression profile analysis by microarray to predict responders to anti-TNF biologics in rheumatoid arthritis 3. Biologicals in India - postmarketing surveillance: problems and prospects 4. Infliximab: the experience in Hong Kong 5. Postmarketing surveillance of etanercept in Australia up to June 2004 6. The open-label evaluation of the efficacy and safety of etanercept in patients with active rheumatoid arthritis and ankylosing spondylitis
- Source :
- Modern Rheumatology; Dec2004, Vol. 14 Issue 6, p502-504, 3p
- Publication Year :
- 2004
-
Abstract
- Presents several abstracts related to the efficacy and safety of tumor necrosis factor (TNF)-alpha blockers in rheumatoid arthritis. Expression profile analysis by microarray to predict responders to anti-TNF biologics in rheumatoid arthritis; Postmarketing surveillance of etanercept in Australia; Open-label evaluation of the efficacy and safety of etanercept in patients with active rheumatoid arthritis and ankylosing spondylitis.
- Subjects :
- TUMOR necrosis factors
RHEUMATOID arthritis
BIOLOGICALS
ETANERCEPT
Subjects
Details
- Language :
- English
- ISSN :
- 14397595
- Volume :
- 14
- Issue :
- 6
- Database :
- Complementary Index
- Journal :
- Modern Rheumatology
- Publication Type :
- Academic Journal
- Accession number :
- 15286296
- Full Text :
- https://doi.org/10.3109/s10165-004-0352-z